Literature DB >> 10753483

Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease.

L L Trépanier1, R Kumar, A M Lozano, A E Lang, J A Saint-Cyr.   

Abstract

This paper highlights the neuropsychological sequelae of posteroventral pallidotomy (PVP) and deep brain stimulation (DBS) of the subthalamic nucleus (STN) and the internal segment of the globus pallidus (GPi) at 3/6 months postoperatively. Results are based on our extensive experience with PVP and our preliminary observations with DBS. Patients with borderline cognitive or psychiatric functioning risk postoperative decompensation. Nonlateralizing attentional and hemisphere-specific impairments of frontostriatal cognitive functions followed unilateral PVP. "Frontal" behavioral dyscontrol was observed in approximately 25% of patients. Three cases of staged bilateral PVP suggest that premorbid factors may predict outcome, although lesion size and location are also critical. Older patients are at risk for significant cognitive and behavioral decline after bilateral STN DBS, while GPi DBS may be safer. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753483     DOI: 10.1006/brcg.1999.1108

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  50 in total

1.  Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus.

Authors:  Christelle Baunez; Marianne Amalric; Trevor W Robbins
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

2.  Defining a role for the subthalamic nucleus within operative theoretical models of subcortical participation in language.

Authors:  B-M Whelan; B E Murdoch; D G Theodoros; B Hall; P Silburn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 3.  A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition.

Authors:  Marjan Jahanshahi; Ignacio Obeso; John C Rothwell; José A Obeso
Journal:  Nat Rev Neurosci       Date:  2015-11-04       Impact factor: 34.870

4.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

5.  Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?

Authors:  V Czernecki; B Pillon; J L Houeto; M L Welter; V Mesnage; Y Agid; B Dubois
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

6.  Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease.

Authors:  K Kalteis; H Standhardt; I Kryspin-Exner; T Brücke; D Volc; F Alesch
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

7.  Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.

Authors:  D De Gaspari; C Siri; A Landi; R Cilia; A Bonetti; F Natuzzi; L Morgante; C B Mariani; E Sganzerla; G Pezzoli; A Antonini
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 8.  Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications.

Authors:  Atchar Sudhyadhom; Frank J Bova; Kelly D Foote; Christian A Rosado; Lindsey Kirsch-Darrow; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

9.  Dissociable dorsal and ventral frontostriatal working memory circuits: evidence from subthalamic stimulation in Parkinson's disease.

Authors:  Jocelyne Ventre-Dominey; Stéphanie Bourret; Hélène Mollion; Emmanuel Broussolle; Peter Ford Dominey
Journal:  Hum Brain Mapp       Date:  2012-10-25       Impact factor: 5.038

10.  Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease.

Authors:  A Daniele; A Albanese; M F Contarino; P Zinzi; A Barbier; F Gasparini; L M A Romito; A R Bentivoglio; M Scerrati
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.